Literature DB >> 2049257

Skin irritation induced by topically applied timolol.

K Kubota1, E Koyama, K Yasuda.   

Abstract

1. Erythema induced by topically applied timolol, a non-selective beta-adrenoceptor blocker, was assessed in six male volunteers. Intensity of erythema developed on the inner surface of the left forearm where timolol free base was applied for 10 h was measured by a visual score, laser doppler flowmeter and reflectance spectrophotometry. Plasma timolol concentrations collected from the left and right arms were also measured. 2. The mean values for blood volume and blood flow per unit volume of tissue both of which were assessed by a laser doppler flowmeter, haemoglobin index measured by reflectance spectrophotometry, and magnitude of erythema graded by a visual score significantly increased after the application of an acrylic co-polymer adhesive patch containing 20% (w/v) timolol free base. 3. Plasma timolol concentrations collected from the left antecubital vein were 2.4 to 10.7 times greater than those from the right arm and had significant correlations (rs = 0.55 to 0.76) with the parameters indicating the extent of erythema developed where a patch containing timolol was applied. 4. The inter-individual variation of timolol was attributed to that of the diffusivity of timolol through skin rather than that of the skin reactivity to topically applied timolol because the plasma timolol concentrations drawn from the left arm in the subjects who did not develop erythema were very low.(ABSTRACT TRUNCATED AT 250 WORDS)

Entities:  

Mesh:

Substances:

Year:  1991        PMID: 2049257      PMCID: PMC1368336          DOI: 10.1111/j.1365-2125.1991.tb05564.x

Source DB:  PubMed          Journal:  Br J Clin Pharmacol        ISSN: 0306-5251            Impact factor:   4.335


  23 in total

1.  A novel differentiation method of vehicle models for topically applied drugs: application to a therapeutic timolol patch.

Authors:  K Kubota; T Yamada; A Ogura; T Ishizaki
Journal:  J Pharm Sci       Date:  1990-02       Impact factor: 3.534

2.  Evaluation of the therapeutic effect of transdermal beta-blocker therapy in patients with essential hypertension.

Authors:  C Spieker; W Vetter; W Zidek; H Vetter
Journal:  Arzneimittelforschung       Date:  1989-11

3.  Effect of beta adrenergic stimulation and blockade on cutaneous reactivity to histamine.

Authors:  N Lamkin; P Lieberman; R Shereff; E W Rosenberg; H Robinson
Journal:  J Allergy Clin Immunol       Date:  1976-05       Impact factor: 10.793

4.  Effect of beta adrenergic stimulation and blockade on immediate hypersensitivity skin test reactions.

Authors:  R H Shereff; W Harwell; P Lieberman; E W Rosenberg; H Robinson
Journal:  J Allergy Clin Immunol       Date:  1973-12       Impact factor: 10.793

Review 5.  Drug therapy: atenolol and timolol, two new systemic beta-adrenoceptor antagonists.

Authors:  W H Frishman
Journal:  N Engl J Med       Date:  1982-06-17       Impact factor: 91.245

6.  Reflectance spectrophotometric quantification of skin colour changes induced by topical corticosteroid preparations.

Authors:  J W Feather; K S Ryatt; J B Dawson; J A Cotterill; D J Barker; D J Ellis
Journal:  Br J Dermatol       Date:  1982-04       Impact factor: 9.302

7.  The soap chamber test. A new method for assessing the irritancy of soaps.

Authors:  P J Frosch; A M Kligman
Journal:  J Am Acad Dermatol       Date:  1979-07       Impact factor: 11.527

8.  Glutaraldehyde (pentanedial) allergic contact dermatitis. Usage test on sole and antecubital fossa: regional variations in response.

Authors:  H I Maibach; S D Prystowsky
Journal:  Arch Dermatol       Date:  1977-02

9.  Assessment of skin irritancy in man by laser Doppler flowmetry.

Authors:  G E Nilsson; U Otto; J E Wahlberg
Journal:  Contact Dermatitis       Date:  1982-11       Impact factor: 6.600

10.  An animal model for nonimmunologic contact urticaria.

Authors:  A Lahti; H I Maibach
Journal:  Toxicol Appl Pharmacol       Date:  1984-11       Impact factor: 4.219

View more
  4 in total

1.  Iontophoretic in vivo transdermal delivery of beta-blockers in hairless rats and reduced skin irritation by liposomal formulation.

Authors:  Rajkumar Conjeevaram; Ayyappa Chaturvedula; Guru V Betageri; Gangadhar Sunkara; Ajay K Banga
Journal:  Pharm Res       Date:  2003-09       Impact factor: 4.200

2.  Pharmacokinetics and beta-blocking effects of transdermal timolol.

Authors:  K Kubota; T Yamada; K Kikuchi; E Koyama; T Ishizaki
Journal:  Eur J Clin Pharmacol       Date:  1993       Impact factor: 2.953

3.  Carbopol/chitosan based pH triggered in situ gelling system for ocular delivery of timolol maleate.

Authors:  Swati Gupta; Suresh P Vyas
Journal:  Sci Pharm       Date:  2010-10-05

Review 4.  Systemic delivery of β-blockers via transdermal route for hypertension.

Authors:  Abdul Ahad; Fahad I Al-Jenoobi; Abdullah M Al-Mohizea; Naseem Akhtar; Mohammad Raish; Mohd Aqil
Journal:  Saudi Pharm J       Date:  2014-01-03       Impact factor: 4.330

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.